These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 2787334)

  • 1. Reliable confirmation of antibodies to human immunodeficiency virus type 1 (HIV-1) with an enzyme-linked immunoassay using recombinant antigens derived from the HIV-1 gag, pol, and env genes.
    Ng VL; Chiang CS; Debouck C; McGrath MS; Grove TH; Mills J
    J Clin Microbiol; 1989 May; 27(5):977-82. PubMed ID: 2787334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens.
    Ravanshad M; Sabahi F; Mahboudi F; Kazemnejad A
    Saudi Med J; 2006 Jan; 27(1):31-6. PubMed ID: 16432590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Accurate Confirmation of Human Immunodeficiency Virus Type 1 (HIV-1) and 2 (HIV-2) Infections with a Dot blot assay Using Recombinant p24, gp41, gp120 and gp36 Antigens.
    Ravanshad M; Sabahi F; Mahboudi F; Roostaee MH; Forooshani RS; Kazemnejad A
    Int J Med Sci; 2004; 1(3):193-200. PubMed ID: 15912198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity and specificity of anti-HIV ELISA employing recombinant (p24, p66, gp120) and synthetic (gp41) viral antigenic peptides.
    Filice G; Soldini L; Orsolini P; Razzini E; Gulminetti R; Campisi D; Chiapparoli L; Cattaneo E; Achilli G
    Microbiologica; 1991 Jul; 14(3):185-94. PubMed ID: 1717811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a confirmatory enzyme-linked immunosorbent assay for HIV-1 antibodies.
    Chiang CS; Grove T; Cooper M; Cuan J; Kowalski A; Parcells K; Tsunokawa M; Rosenberg M; Arcuri E; Franklin S
    Clin Chem; 1989 Jun; 35(6):946-52. PubMed ID: 2659223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliable detection of individuals seropositive for the human immunodeficiency virus (HIV) by competitive immunoassays using Escherichia coli-expressed HIV structural proteins.
    Dawson GJ; Heller JS; Wood CA; Gutierrez RA; Webber JS; Hunt JC; Hojvat SA; Senn D; Devare SG; Decker RH
    J Infect Dis; 1988 Jan; 157(1):149-55. PubMed ID: 3275722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies reactive with human immunodeficiency virus gag-coded antigens (gag reactive only) are a major cause of enzyme-linked immunosorbent assay reactivity in a blood donor population.
    Tribe DE; Reed DL; Lindell P; Kenealy WR; Ferguson BQ; Cybulski R; Winslow D; Waselefsky DM; Petteway SR
    J Clin Microbiol; 1988 Apr; 26(4):641-7. PubMed ID: 3259246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliable confirmation and quantitation of human immunodeficiency virus type 1 antibody using a recombinant-antigen immunoblot assay.
    Busch MP; el Amad Z; McHugh TM; Chien D; Polito AJ
    Transfusion; 1991 Feb; 31(2):129-37. PubMed ID: 1899951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-directed enzyme-linked immunosorbent assay with a synthetic simian immunodeficiency virus SIVmac peptide identifying antibodies against the HIV-2 transmembrane glycoprotein.
    Norrby E; Chiodi F; Whalley A; Parks E; Nauclér A; Costa CM; Torstensson R; Biberfeld G
    AIDS; 1989 Jan; 3(1):17-20. PubMed ID: 2469436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic env gp41 peptide as a sensitive and specific diagnostic reagent in different stages of human immunodeficiency virus type 1 infection.
    Närvänen A; Korkolainen M; Suni J; Korpela J; Kontio S; Partanen P; Vaheri A; Huhtala ML
    J Med Virol; 1988 Oct; 26(2):111-8. PubMed ID: 2460585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of human serum antibodies to human immunodeficiency virus (HIV) using recombinant ENV and GAG antigens.
    Kenealy W; Reed D; Cybulski R; Tribe D; Taylor P; Stevens C; Matthews T; Petteway S
    AIDS Res Hum Retroviruses; 1987; 3(1):95-105. PubMed ID: 3304356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of serum HIV-Ag related to the major core protein (p24) in persons at risk for AIDS.
    Borghi V; De Rienzo B; Pietrosemoli P; Pecorari M; Mongiardo N; Pellegrino F; Zanchetta GP; Lami G; Squadrini F
    Microbiologica; 1989 Jan; 12(1):81-3. PubMed ID: 2497304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. False-positive sera do not react with human immunodeficiency virus (HIV) gag-encoded recombinant antigen.
    Bukrinsky MI; Syrtsev VA; Popov SA; Barsov EV; Chaplinskas SA; Karamov EV
    J Med Virol; 1989 Jan; 27(1):72-5. PubMed ID: 2466101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a line immunoassay for simultaneous confirmation of antibodies to HIV-1 and HIV-2.
    Fransen K; Pollet DE; Peeters M; van Kerckhoven I; Beelaert G; Vercauteren G; Piot P; van der Groen G
    Eur J Clin Microbiol Infect Dis; 1991 Nov; 10(11):939-46. PubMed ID: 1794364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More reliable diagnosis of infection with human immunodeficiency virus type 1 (HIV-1) by detection of antibody IgGs to pol and gag proteins of HIV-1 and p24 antigen of HIV-1 in urine, saliva, and/or serum with highly sensitive and specific enzyme immunoassay (immune complex transfer enzyme immunoassay): a review.
    Hashida S; Hashinaka K; Ishikawa S; Ishikawa E
    J Clin Lab Anal; 1997; 11(5):267-86. PubMed ID: 9292394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of recombinant human immunodeficiency virus gag precursor and gag/env fusion proteins and a synthetic env peptide as diagnostic reagents.
    Shoeman RL; Young D; Pottathil R; Victor J; Conroy RR; Crowl RM; Coleman T; Heimer E; Lai CY; Ganguly K
    Anal Biochem; 1987 Mar; 161(2):370-9. PubMed ID: 3495201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterially expressed core and envelope proteins of human immunodeficiency virus type-1 (HIV-1): comparative evaluation in detection of type-specific antibodies.
    Kovác J; Zachar V; Brůcková M; Ujhélyi E; Füst G; Mayer V; Zajac V
    Acta Virol; 1992 Aug; 36(4):337-46. PubMed ID: 1282776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variations in Western blot banding patterns of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus.
    Burke DS; Redfield RR; Putman P; Alexander SS
    J Clin Microbiol; 1987 Jan; 25(1):81-4. PubMed ID: 3540002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An ELISA-inhibition assay for antibody to human immunodeficiency virus core antigen (p24).
    Povolotsky J; Gold JW; Darminin P; Chein N; Baron P; Armstrong D
    J Virol Methods; 1990 Oct; 30(1):109-14. PubMed ID: 2128300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 neutralizing antibodies in urine from seropositive individuals.
    Cao YZ; Friedman-Kien AE; Mirabile M; Li XL; Alam M; Dieterich D; Ho DD
    J Acquir Immune Defic Syndr (1988); 1990; 3(3):195-9. PubMed ID: 1968094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.